Holger Wesche Harpoon Therapeutics, Inc. (HARP) insider trading activity

Holger Wesche is Chief Scientific Officer of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 52,852 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2021, when has been sold 10,000 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $140,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.9K

0% 3M change

0% 12M change

Total Value Held $0

Holger Wesche Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 01 2021	SELL Open market or private sale	$140,000 $14.0 p/Share	10,000 Reduced 15.91%	52,852 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 13.73%	62,852 Common Stock
Apr 01 2021	SELL Open market or private sale	$207,800 $20.78 p/Share	10,000 Reduced 15.91%	52,852 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 13.73%	62,852 Common Stock
Jan 04 2021	SELL Open market or private sale	$183,400 $18.34 p/Share	10,000 Reduced 15.91%	52,852 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 13.73%	62,852 Common Stock
Oct 01 2020	SELL Open market or private sale	$166,100 $16.61 p/Share	10,000 Reduced 15.96%	52,669 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$6,000 $0.6 p/Share	10,000 Added 13.76%	62,669 Common Stock

Holger Wesche

Chief Scientific Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HARP shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Harpoon Therapeutics, Inc. insider buys or sells HARP shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Harpoon Therapeutics, Inc.

Track Activities on HARP

Account